Literature DB >> 11127874

The cleaved peptide of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the surface-connected canalicular system.

M I Furman1, P Nurden, M C Berndt, A T Nurden, S E Benoit, M R Barnard, F A Ofosu, A D Michelson.   

Abstract

The only known function of the 41 amino acid cleaved peptide (TR1-41) of the seven transmembrane domain thrombin receptor (PARI) is to activate platelets (as determined by aggregation, surface P-selectin, and fibrinogen binding to activated GPIIb-IIIa). We now demonstrate that TR1-41 results in a concentration-dependent decrease in the platelet surface expression of each component of the GPIb-IX-V complex, as determined by flow cytometry with a panel of monoclonal antibodies (including 6D1, directed against the von Willebrand factor binding site on GPIbalpha, and TM60, directed against the thrombin binding site on GPIbalpha). TR1-41 also decreased ristocetin-induced platelet agglutination. Immunoblotting after incubation of platelets with TR1-41 revealed neither a loss of platelet GPIb nor increase in supernatant GPIb fragments. As demonstrated by immunoelectron microscopy, TR1-41 resulted in a redistribution of GPIb, GPIX, and GPV from the platelet surface to the surface-connected canalicular system (SCCS). In summary, the cleaved peptide (TR1-41) of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the SCCS, thereby negatively regulating the GPIbalpha binding sites for von Willebrand factor and thrombin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127874

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2' and glycoprotein I bα.

Authors:  Wenjing Zhang; Fei Gao; Donghe Lu; Na Sun; Xiaoxue Yin; Meili Jin; Yanhong Liu
Journal:  Front Med       Date:  2015-11-30       Impact factor: 4.592

3.  Mechanisms of action of proteinase-activated receptor agonists on human platelets.

Authors:  Ada W Y Chung; Paul Jurasz; Morley D Hollenberg; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

4.  Anti-Parstatin Promotes Angiogenesis and Ameliorates Left Ventricular Dysfunction during Pressure Overload.

Authors:  Srikanth Givvimani; Nithya Narayanan; Sathnur Basappa Pushpakumar; Suresh C Tyagi
Journal:  Int J Biomed Sci       Date:  2014-03

5.  Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs.

Authors:  Vemuri B Reddy; Shuohao Sun; Ehsan Azimi; Sarina B Elmariah; Xinzhong Dong; Ethan A Lerner
Journal:  Nat Commun       Date:  2015-07-28       Impact factor: 14.919

6.  Proteolytic processing of platelet receptors.

Authors:  Elizabeth E Gardiner
Journal:  Res Pract Thromb Haemost       Date:  2018-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.